Breath-Triggered Drug Release System for Preterm Neonates.

Area of Science:

• Biomedical Engineering
• Neonatal Respiratory Care
• Drug Delivery Systems

Background:

• Continuous nebulization in neonates leads to significant drug loss during exhalation.
• Existing breath-triggered systems are not suitable for preterm neonates due to their unique respiratory characteristics.
• A need exists for an integrated, patient-interface-based system for efficient aerosol delivery in this population.

Purpose of the Study:

• To develop and evaluate a miniaturized, breath-triggered aerosol valve integrated into a nasal prong for preterm neonates.
• To assess the feasibility of triggering drug release using neonatal breathing patterns.
• To quantify the improvement in inhaled aerosol efficiency compared to non-triggered delivery.

Main Methods:

• A miniaturized aerosol valve was integrated into a neonatal nasal prong, actuated by a double-stroke cylinder.
• Breathing was simulated using a test lung mimicking preterm neonate respiratory parameters (CPAP support).
• Inhalation flow was used as the trigger signal for aerosol release; particle detection used gravimetric and optical methods.

Main Results:

• The integrated valve demonstrated a rapid response time of less than 25 milliseconds.
• Breath-triggered release significantly increased inhaled aerosol efficiency by over fourfold compared to continuous delivery.
• The system successfully delivered humidified surfactant in a triggered bolus during simulated inhalation.

Conclusions:

• A novel nasal prong with an integrated, breath-triggered aerosol valve is feasible for preterm neonates.
• This system enhances inhaled aerosol efficiency by delivering medication precisely during inhalation.
• The rapid response time and improved efficiency offer a promising advancement for neonatal inhalation therapy.